Unique ID issued by UMIN | UMIN000050874 |
---|---|
Receipt number | R000051187 |
Scientific Title | Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial |
Date of disclosure of the study information | 2023/04/19 |
Last modified on | 2023/04/18 09:22:39 |
Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial
Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial
Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial
Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial
Africa |
male sexual function
Urology |
Others
NO
Daily use of Duloxetine effect in treating premature ejaculation
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
improvement in premature ejaculation
impact on sexual function and quality of life
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
2
Treatment
Medicine |
34 patients will receive duloxetine then placebo in group A
34 patients will receive placebo then duloxetine in group B
20 | years-old | <= |
45 | years-old | >= |
Male
Male patients with PE (primary or secondary) with stable and committed relationship having (IELT) < 2 minutes were included
Patients with erectile dysfunction (ED), reduced sexual desire or inhibited male orgasm or active genitourinary tract infection (confirmed by two glasses of urine and EPS) or known mental disorders (Depression, Anxiety, Schizophrenia) or uncontrolled physical illnesses (Hepatic, Renal, Cardiac, Neurological, Endocrinal) were excluded from the study. Finally, any alcohol or drug abuser or patient with known hypersensitivity to duloxetine was excluded from the study.
100
1st name | sameh |
Middle name | fayek |
Last name | gamalel din |
kasr AlAiny faculty of medicine Cairo university
Andrology & STDs
002
357 C south academy New Cairo
01227109309
samehfayek@hotmail.com
1st name | sameh |
Middle name | fayek |
Last name | gamalel din |
Kasr AlAiny faculty of medicine
Andrology & STDs
002
357 C south academy New Cairo
01227109309
http://scholar.cu.edu.eg/sfayek
samehfayek@hotmail.com
Kasr AlAiny faculty of medicine
Kasr AlAiny faculty of medicine
Self funding
Egypt
Cairo University, Faculty of medicine, Cairo, Egypt
357 C south academy New Cairo
+20 25 729 584
samehfayek@hotmail.com
NO
2023 | Year | 04 | Month | 19 | Day |
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
Unpublished
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
100
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
2023 | Year | 04 | Month | 18 | Day |
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
Nausea was the main side effect reported
Duloxetine is effective and safe in patients with primary and secondary premature ejaculation
No longer recruiting
2022 | Year | 04 | Month | 24 | Day |
2022 | Year | 04 | Month | 24 | Day |
2022 | Year | 05 | Month | 17 | Day |
2022 | Year | 08 | Month | 19 | Day |
2023 | Year | 04 | Month | 18 | Day |
2023 | Year | 04 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051187
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |